| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $32K | — | -100.0% |
| R&D Expense | $16.1M | — | -67.0% |
| SG&A Expense | $10.1M | — | -3.3% |
| Operating Income | -$25.9M | — | -117.0% |
| Pre-tax Income | -$23.7M | — | -115.0% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$23.7M | — | -116.0% |
| EPS (Basic) | -$1.21 | — | -133.1% |
| EPS (Diluted) | -$1.21 | — | -133.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $281.5M | -2.1% | -60.9% |
| Accounts Receivable | $400K | -88.8% | -97.7% |
| Current Assets | $290.7M | -7.8% | -61.7% |
| Total Assets | $312.3M | -7.6% | -60.2% |
| Current Liabilities | $12.9M | -37.0% | -67.4% |
| Total Liabilities | $26.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.5M | — | -102.2% |
| Capital Expenditures | $73K | — | -87.1% |
| Investing Cash Flow | -$73K | — | +87.1% |
| Financing Cash Flow | -$2.3M | — | — |
| Free Cash Flow | -$3.6M | — | -102.2% |
| -52.1% |
| Stockholders' Equity | $285.6M | -5.8% | -60.8% |